A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...

Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...

A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...

A new study from UCSF reveals an “alarming” rise in advanced prostate cancer rates across California. The findings, published ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new study.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

(RTTNews) - RedHill Biopharma (RDHL) Tuesday announced that it has launched a Phase 2 trial to assess opaganib's ability to enhance darolutamide in treating metastatic castrate-resistant prostate ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Recent scientific studies have shown promising advancements in medical treatments. A personalized vaccine significantly ...

First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...